The nation’s leader in stem cell marketing, R3 Stem Cell, has effectively incorporated artificial intelligence into client marketing. The technology has been effective at reducing patient acquisition costs by over thirty percent.
For over six years, R3 Stem Cell has been working with clients nationwide on patient acquisition marketing programs. Traditional marketing for stem cell patients involves a considerable spend with a very low yield. R3 Stem Cell uses state of the art methods to reach a more targeted audience that has a much higher yield than the traditional methods.
One of the most exciting methods R3 uses has been artificial intelligence. This involves analyzing live phone calls with a machine to understand how the best leads correlate with certain keywords, times of day, geography and how the calls are handled at the practice.
Read More: Bringing Collaboration to the Midmarket
It is well known that most clients have no method of handling the ridiculous amounts of data available to them and make useful decisions. So most practices simply use traditional marketing methods which are expensive and low yield.
Said R3 Stem Cell Marketing CEO Dr. David Greene, “While artificial intelligence is complicated, we have developed a proprietary system that uses available data to figure out what is working best so we can deploy resources better and more cost effectively. This helps clients big time!”
Every month, R3’s marketing team generates thousands of prospective patient leads nationwide. The AI methods have dramatically assisted in the effort, along with the sales training that is taught in conjunction.